Expression of survivin and Ki67 in diffusely infiltrating astrocytoma and their clinicopathological significances

黄颖,陈雪芹,陈铌,周桥
DOI: https://doi.org/10.3969/j.issn.2095-1752.2012.33.075
2012-01-01
Abstract:Objective: In order to analysis the expression feature of a member of the inhibitor of apoptosis protein (IAP) family survivin, and cel proliferation index Ki67 in diffusely infiltrating astrocytoma, and to explore their relationship with clinicopathologic characteristics and prognosis. Methods: With conventional reverse transcription-PCR, We measured mRNA expressions of survivin in 73 diffusely infiltrating astrocytomas, 12 normal brain tissues (NBT). We also investigated the expression of total survivin protein by Western blot and immunohistochemistry. We compared the expression of survivin protein with Ki67 by immunohistochemistry. Results: The expression of survivin mRNA (60.3%, 44/73), survivin protein (56.2%, 41/73), the average survivin nuclear labeling index (survivin-N, 5.67%) and proliferative index Ki67 (8.39%) in diffusely infiltrating astrocytomas were significantly higher than the normal control (P<0.05). The expression frequencies of survivin mRNA, survivin protein were increased with increasing WHO grade and were associated with poor prognosis and recurrence or death (P<0.01), and survivin nuclear labeling index was closely associated with proliferative index Ki67 (r=0.899,P<0.05). Conclusion: The expression of survivin and Ki67 in diffusely infiltrating astrocytomas are closely related with WHO grade and prognosis. Evaluation of survivin-N and Ki67 may identify patients of diffusely infiltrating astrocytomas at higher risk of recurrence and tumor-related death, and may play an role in Guiding clinical treatment.
What problem does this paper attempt to address?